Abstract
The solvent of commercial amiodarone (Polysorbate 80) has been reported to produce haemodynamic responses in humans and in dogs similar to those produced by histamine infusion. We therefore evaluated the correlation between hypotension induced by the solvent of amiodarone and its histamine-releasing properties in the awake dog.
The solvent of amiodarone administered to a dog, over 5 min in a dose of 10 mg/kg of Polysorbate 80, produced severe hypotension after the first administration; the second injection (24 h later) caused fewer hypotensive effects.
Histamine release in the peripheral tissues was demonstrated by a marked increase in plasma histamine concentrations, with the maximum value 10 min after the solvent administration. H1- and H2-receptor blockade with mepyramine (5 mg/kg) and cimetidine (10 mg/kg) significantly reduced the cardiovascular effects of the solvent.
Isolated peritoneal mast cells from rats also released histamine in response to Polysorbate 80. These studies show that Polysorbate 80 releases histamine bothin vitro and in isolated mast cells from rats andin vivo in the dog, and that the plasma concentrations are correlated with the haemodynamic responses.
Similar content being viewed by others
References
M. Alam, G.V. Anrep, G.S. Barsoum, M. Talaat andE. Wieninger,Liberation of histamine from skeletal muscle by curare, J. Physiol., Lond.95, 148–158 (1939).
P.L. Smith, A. Kagey-Sobotka, E.R. Bleecker, R. Traystman, A.P. Kaplan, H. Gralnick, M.D. Valentine, S. Permutt andL.M. Lichtenstein,Physiological manifestations of human anaphylaxis, J. clin. Invest.66, 1072–1080 (1980).
J. Moss, N. Fahmy, N. Sunder andM.A. Beaven,Hormonal and hemodynamic profile of anaphylactic reaction in man, Circulation63, 210–213 (1981).
K. Pavek, A. Wegmann, L. Nordström andD. Schwander,Cardiovascular and respiratory mechanisms in anaphylactic and anaphylactoid shock reactions, Klin. Wschr.60, 941–947 (1982).
C. Meyer-Burgdorff, G. Seidel andF.J. Schlüter,Freisetzung von Histamin und Serotonin bei extrakorporaler Zirkulation, Anaesthesist22, 212–216 (1973).
H.G. Beger andD. Stopix,Histamine release and hepatic elimination of histamine following abdominal surgery, Klin. Wschr.60, 935–938 (1982).
W. Lorenz, A. Doenicke, B. Schöning andE. Neugebauer, The role of histamine in adverse reactions to intravenous agents. InAdverse Reactions to Anaesthetic Drugs, pp. 169–238 (Ed.J.A. Thornton) Elsevier, North-Holland Biomedical Press, Amsterdam 1981.
C. Meyer-Burgdorff, G. Seidel andI. Wolf,Histaminfreistzung durch Narkosemittel, Anaesthesist25, 1–5 (1976).
J. Moss, C.D. Rosow, J.J. Savarese, D.M. Philbin andK.F. Kniffen,Role of histamine in the hypotensive action of d-tubocuranine in humans, Anaesthesiology55, 19–25 (1981).
D.M. Philbin, J. Moss, C.W. Akins, C.E. Rosow, K.,R.C. Schneider, T.R. Verlee andJ.J. Savarese,The use of H 1-and H 2-histamine antagonists with morphine anaesthesia: a double blind study, Anaesthesiology55, 292–296 (1981).
C.E. Rosow, J. Moss, D.M. Philbin andJ.J. Savarese, Histamine release during morphine and fentanyl anesthesia. Anaesthesiology56, 93–96 (1982).
S.D., Rockoff andU.T. Aker,Contrast media as histamine liberators: VI. Arterial plasma histamine and hemodynamic responses following angiocardiography in man with 75% hypaque, Invest. Radiol.7, 403–406 (1972).
W. Lorenz, A. Doenicke, B. Schöning, C.H. Ohmann, B. Grote andE. Neugebauer,Definition and classification of histamine-release response to drugs in anaesthesia and surgery: studies in the conscious human subject, Klin. Wschr.60, 896–913 (1982).
M.R. Bristow, W.S. Sageman, R.H. Scott, M.E. Billingham, R.E. Bowder, R.S. Kernoff, G.H. Snidow andJ.R. Daniels,Acute and chronic cardiovascular effects of Doxorubicin in dog: the cardiovascular pharmacology of drug-induced histamine release, J. Cardiovasc. Pharmac.2, 487–515 (1980).
A. Eschalier, M. Rodriguez, C. Burtin andJ. Lavarenne,Acute cardiovascular effects of several antitumor agents in the dog: involvement of histamine, Naunyn-Schmiedeberg's Arch. Pharmak. Supplement 324, Abs.256 (1983).
W. Lorenz, A. Schmal, H. Schult, S. Lang, C.H. Ohmann, D. Weber, B. Kappa, L. Luben andA. Doenicke,Histamine release and hypotensive reactions in dogs by solubilizing agents and fatty acids: analysis of various components of Cremophor El ® and development of a component with reduced toxicity, Agents and Actions12, 64–81 (1982).
W. Lorenz, A. Doenicke, R. Meyer, H.J. Reimann, J. Kusche, H. Barth, H. Geesing, M. Hutzel andB. Weissenbacher,Histamine release in man by Propanidid and Thiopentone: pharmacological effects and clinical consequences, Br. J. Anaesth.44, 355–369 (1972).
W. Lorenz, A. Doenicke, R. Meyer, H.J. Reimann, J. Kusche, H. Barth, H. Geesing, M. Hutzel andB. Weissenbacher,An improved method for the determination of histamine release in man: its application in studies with propanidid and thiopentone, Eur. J. Pharmac.19, 180–190 (1972).
A. Doenicke, W. Lorenz, R. Beigl, H. Bezecny, G. Uhlig, L. Kalmar, B. Praetorius andG. Mann,Histamine release after intravenous application of short-acting hypnotics: a comparison of etomidate, althesin (CT 1314) and propanidid, Br. J. Anaesth.45, 1097–1104 (1973).
P. Cote, M.G. Bourassa, J. Delaye, A. Janin, R. Froment andP. David,Effects of amiodarone on cardiac and coronary hemodynamic and on myocardial metabolism in patients with coronary artery disease, Circulation59, 1165–1172 (1979).
R. Charlier, G. Deltour, A. Baudine andF. Chaillet,Pharmacology of Amiodarone, an antianginal drug with a new biological profile, Arzneimittel-Forsch.18, 1408–1417 (1968).
N. El-Sherif, R.R. Hope, B.J. Sherlag andR. Lazzara,Reentrant ventricular arrhythmias in the late myocardial infarction period. 1. Conduction characteristics in the infarction zone, Circulation55, 686–701 (1977).
N. El-Sherif, R.R. Hope, B.J. Sherlag andR. Lazzara,Reetrant arrhythmias in the late myocardial infarction period. 2. Patterns of initiation and termination of reentry, Circulation55, 702–719 (1977b).
J.T. Bigger, A.L. Basseit andB.F. Hoffman,Electrophysiological effects of diphenylhydantoin on canine Purkinje fibers, Circulation Res.22, 221–236 (1968).
W.B. Gough, R.H. Zeiler, P. Barreca andN. El-Sherif,Hypotensive action of commercial intravenous amiodarone and polysorbate 80 in dogs, J. Cardiovasc. Pharmac.4, 375–380 (1982).
W. Lorenz, H.J. Reimann, A. Schmal, P. Dormann, B. Schwarz andE. Neugebauer,Histamine release in dogs by Cremophor El ® and its derivatives: oxethylated oleic acid is the most effective constituent, Agents and Actions7, 63–67 (1977).
R.S.J. Clarke, J.W. Dundee, T. Garrett, G.K. McArdle andJ.S. Sutton,Adverse reactions to intravenous anaesthetics. Br. J. Anaesth.47, 575–585 (1975).
B. Unväs andI.L. Thon,Evidence for enzymatic histamine release from isolated rat mast cells, Expl. Cell. Res.23, 45–57 (1961).
P.A. Shore, A. Burkhalter andV.H. Cohn,A method for the fluorimetric assay of histamine in tissue, J. Pharmac. exp. Ther.127, 182–186 (1959).
L.T. Kremzner andI.R. Wilson,A procedure for the determination of histamine, Biochim. biophys. Acta50, 364–367 (1961).
H.U. Bergmeyer andE. Bernt, Lactate dehydrogenase. UV-Assay with pyruvate and NADH. InMethods of Enzymatic Analysis, vol. 2, pp. 574–579 (Ed.H.U. Bergmeyer) Verlag Chemic Academic Press, New York, 1974.
W. Lorenz,Histamine release in man, Agents and Actions,5, 402–416 (1975).
R.T. Garrett, The clinical manifestations of adverse reactions following althesin and thiopentane. InAdverse Response to Intravenous Drugs, pp. 34–40 (EdsJ. Watkins andA.M. Ward) Academic Press, London 1978.
A. Doenicke, Pseudoallergic reactions due to histamine release during intravenous anaesthesia. InPseudoallergic Reactions: Genetic Aspects and Anaphylactoid Reactions, pp. 224–250 (EdsP. Dukor, P. Kallos, H.D. Schlumberger andG.B. West) S. Karger, Basel 1980.
J. Watkins,Anaphylactoid reactions to i.v. substances, Br. J. Anaesth.51, 51–60 (1979).
W. Lorenz andA. Doenicke, Anaphylactoid reactions and histamine release by intravenous drugs used in surgery and anaesthesia. InAdverse response to Intravenous Drugs, pp. 83–112 (Eds.J. Watkins andA.M. Ward) Academic Press, London 1978.
J.B. Glen, G.E. Davies, D.S. Thomson, S.C. Scarth andA.V. Thompson, Adverse reaction to intravenous anaesthetics in animals. InAdverse Response to Intravenous Drugs, pp. 129–135 (Eds.J. Watkin andA.M. Ward) Academic Press, London 1978.
J.B. Glen, G.E. Davies, D.S. Thomson, S.C. Scarth andA.V. Thompson,An animal model for the investigation of adverse response to i.v. anaesthetic agents and their solvents, Br. J. Anaesth.51, 819–827 (1978).
W. Schmutzler,Histamine release from human adenoidal mast cells induced by anti-human IgE, acetylcholine Epontol ®,Chremophor El ® and 12-hydroxystearic acid, Allergologie, in press.
M. Werner andE. Wolff, Klinisch-experimentelle Untersuchungen zur Frage der Propanidid-Allergie. In (EdsM. Zindler, H. Yamamura, W. Wirth) Springer-Verlag, Heidelberg, New York 1973).
M. Thermann, W. Lorenz, A. Schmal, F. Schingale, P. Dormann andH. Hamelmann Alterations in the circulatory system of anaesthetized dogs following administration of histamine and histamine H 1-and H 2-receptor antagonists in relation to plasma histamine levels, Agents and Actions5, 450–455 (1975).
S.C. Verma andJ.H. McNeill Cardiac histamine receptors: differences between right and left atria and right ventricle, J. Pharmac. exp. Ther.200, 352–362 (1977).
R. Ginsburg, M.R. Bristow andE.B. Stinson,Histamine receptors in the human heart, Life Sci.26, 2245–2249 (1980).
J. Moss, N.R. Fahmy, N. Sunder andM.A. Beaven,Hormonal and hemodynamic profile of an anaphylactic reaction in man, Circulation63, 210–213 (1981).
W. Lorenz, R. Meyer, A. Doenicke, A. Schmal, H.J. Reimann, M. Hutzel andE. Werle,On the species specificity of the histamine release from mast cell stores by Cremophor El ®, Naunyn-Schmiedeberg's Arch. Pharmak.269, 417–421 (1971).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Masini, E., Planchenault, J., Pezziardi, F. et al. Histamine-releasing properties of Polysorbate 80in vitro andin vivo: correlation with its hypotensive action in the dog. Agents and Actions 16, 470–477 (1985). https://doi.org/10.1007/BF01983649
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01983649